Position in INVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,553,226
+$911,126 QoQ
Shares Held
68,394
+148.2% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 307 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. INVA ranks #117 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in INVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,553,226 | 68,394 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $642,100 | 27,558 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,404,057 | 70,238 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $747,702 | 40,970 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $694,992 | 34,594 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $633,170 | 34,924 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $642,331 | 37,022 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $509,493 | 26,385 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $408,392 | 24,902 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $328,024 | 21,524 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $317,991 | 19,825 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $208,618 | 16,060 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $363,708 | 28,571 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $193,859 | 17,232 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $473,527 | 35,738 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $432,459 | 37,249 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $95,289 | 6,456 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,523,143 | 130,395 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,298,406 | 133,241 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,700,570 | 281,303 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,712,888 | 351,446 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,352,762 | 280,566 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,052,807 | 246,393 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $2,564,553 | 245,412 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $2,581,559 | 184,661 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,899,874 | 161,554 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||